Scientists discover the nutrient that supercharges cellular energy

 



A research group led by Professor Dr. Thorsten Hoppe at the University of Cologne's Institute for Genetics and the CECAD Cluster of Excellence on Aging Research has now identified a new biological pathway showing how the amino acid leucine strengthens mitochondrial performance. Their work reveals that leucine stabilizes important mitochondrial proteins, enhancing the organelle's ability to produce energy. The study, titled "Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration," was published in Nature Cell Biology

How Leucine Supports Energy Production

Leucine is one of the essential amino acids, meaning it must be obtained through food. It is a key component of protein synthesis and is abundant in protein-rich foods like meat, dairy products, and legumes such as beans and lentils. The researchers found that leucine helps protect certain proteins on the outer membrane of mitochondria from breaking down. These proteins are vital because they transport other metabolic molecules into the mitochondria to generate energy. By preserving them, leucine allows mitochondria to work more efficiently, resulting in higher energy output within the cell.

"We were thrilled to discover that a cell's nutrient status, especially its leucine levels, directly impacts energy production," said Dr. Qiaochu Li, the study's first author. "This mechanism enables cells to swiftly adapt to increased energy demands during periods of nutrient abundance."

The study also revealed that a protein called SEL1L plays an important role in this process. SEL1L is part of the cell's quality control system that identifies and removes faulty or misfolded proteins. Leucine seems to reduce the activity of SEL1L, which decreases the breakdown of mitochondrial proteins and improves mitochondrial performance. "Modulating leucine and SEL1L levels could be a strategy to boost energy production," said Li. "However, it is important to proceed with caution. SEL1L also plays a crucial role in preventing the accumulation of damaged proteins, which is essential for long-term cellular health."

Broader Implications for Health and Disease

To explore the wider impact of their findings, the researchers studied the process in the model organism Caenorhabditis elegans. They discovered that problems in leucine metabolism can impair mitochondrial function and even cause fertility issues. When the team examined human lung cancer cells, they found that certain mutations affecting leucine metabolism actually help cancer cells survive, highlighting an important factor for future cancer treatment strategies.

#CellularEnergy
#Mitochondria
#Bioenergetics
#MetabolismBoost
#EnergyScience
#NutrientDiscovery
#CellBiology
#HealthInnovation
#ScientificBreakthrough
#Biochemistry

World Cell Biologist Awards: 

Website Link : cellbiologist.org 

Follow Us On : 
Tumblr ; tumblr.ccom/






Comments

Post a Comment

Popular posts from this blog

Uttrakhand Forest Department Establishes Mahabharata Vatika

Image
  The Uttarakhand Forest Department has established two gardens in Haldwani, showcasing plant species referenced in ancient Indian epics. These gardens, named Ramayana Vatika and Mahabharata Vatika, aim to highlight the ecological wisdom embedded in these texts. Mahabharata Vatika Overview Mahabharata Vatika spans one acre and features 37 plant species mentioned in the epic. Chief Conservator of Forests Sanjeev Chaturvedi emphasised the research behind selecting these species. The garden features important plant species such as: Ecological Significance The garden puts stress on the importance of forests as depicted in the Mahabharata. It references the Vana Parva, which discusses tree planting and wildlife conservation . The epic highlights the mutual dependence of tigers and forests, a concept vital to contemporary conservation efforts. Cultural Connections Chaturvedi brought into light that the Mahabharata teaches the spiritual significance of planting trees. He mentioned Bhish...
Read more

What is Zolgensma?

Image
  Spinal Muscular Atrophy (SMA) is a rare genetic disease affecting muscle function. In India, treatment options are limited, mainly due to high costs. The gene therapy drug, Zolgensma , costs around 16 crore rupees. Despite this, some families are finding ways to access treatment. About Spinal Muscular Atrophy (SMA) SMA is a genetic disorder that leads to the loss of motor neurons in the spinal cord. This results in muscle weakness and atrophy. Symptoms often appear in infancy. Children may struggle with basic movements like lifting their heads or crawling. Early diagnosis is crucial for effective treatment. About Zolgensma Zolgensma (onasemnogene abeparvovec-xioi) is a revolutionary gene therapy for SMA. It addresses the root cause by replacing the missing or defective SMN1 gene . This therapy can improve motor function in affected children. Although it is costly, it represents hope for many families. SMA is not as rare as once thought. The global prevalence is estimated at 1 in ...
Read more

CAR T-Cell Therapy for Cancer

Image
  India has recently made strides in cancer treatment with the introduction of CAR T-cell therapy . The results from the first clinical trials have been published in The Lancet, showcasing a remarkable success rate. This therapy is a game changer for patients with blood cancers. It offers hope to those who have exhausted other treatment options. What is CAR T-Cell Therapy? CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative treatment that harnesses the body’s immune system. It trains T-cells to target and destroy cancer cells. This therapy is specifically designed for certain blood cancers. It is particularly beneficial for patients whose cancer has relapsed or failed to respond to standard treatments. Clinical Trial The clinical trials reported a response rate of nearly 73%. This indicates that number of patients benefited from the treatment. The trials also provided critical data on survival rates for patients with acute lymphoblastic leukaemia and l...
Read more